Ppd Development, Lp
Clinical trials sponsored by Ppd Development, Lp, explained in plain language.
-
New drug trial aims to improve survival in ARDS patients
Disease control Recruiting nowThis study tests a drug called bevacizumab in hospitalized adults with acute respiratory distress syndrome (ARDS), a severe lung condition. About 200 participants will receive either the drug or a placebo to see if it improves survival and oxygen levels. The goal is to find a saf…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for ARDS: major trial tests multiple therapies in hospitalized patients
Disease control Recruiting nowThis study tests several experimental treatments for adults hospitalized with acute respiratory distress syndrome (ARDS), a severe lung condition. About 600 participants will receive either a placebo or an active drug to see if the treatments improve survival and are safe. The go…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug trial aims to help patients with severe lung failure
Disease control Recruiting nowThis Phase 2 trial tests a drug called paridiprubart in hospitalized adults with moderate to severe acute respiratory distress syndrome (ARDS), a serious lung condition. About 200 participants will receive either the drug or a placebo as a single IV dose. The main goal is to see …
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug trial aims to boost survival in severe lung failure patients
Disease control Recruiting nowThis study tests a medicine called vilobelimab in adults hospitalized with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. About 200 participants will receive either the drug or a placebo to see if it improves survival and is safe…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC